Solo Growth Completes Change of Business, Name Change and Announces New Ticker “SOLO”
CALGARY, Alberta, Jan. 07, 2019 (GLOBE NEWSWIRE) — Solo Growth Corp.™ (formerly Aldershot Resources Ltd.) (the “Company” or “Solo Growth”) […]
Glowpoint Receives Additional Time Period From NYSE American to Regain Compliance With Continued Listing Standards
DENVER, Jan. 07, 2019 (GLOBE NEWSWIRE) — Glowpoint, Inc. (NYSE American: GLOW) (“Glowpoint” or the “Company”), a managed service provider […]
Covia Announces Participation in Goldman Sachs Global Energy Conference
INDEPENDENCE, Ohio, Jan. 07, 2019 (GLOBE NEWSWIRE) — Covia (NYSE:CVIA) announced today that it will participate in the Goldman Sachs […]
Suncor Énergie fait une mise à jour de ses activités pour le quatrième trimestre de 2018
CALGARY, Alberta, 07 janv. 2019 (GLOBE NEWSWIRE) — Suncor a fait une mise à jour aujourd’hui de ses activités pour […]
Emergent BioSolutions Announces Preliminary 2018 Financial Results and Provides 2019 Financial Forecast
Full year 2018 preliminary performance in line with recently revised guidance Full year 2019 forecast reflects continued growth of organic […]
Lilly Announces Agreement To Acquire Loxo Oncology
Acquisition will broaden the scope of Lilly’s oncology portfolio into precision medicines through the addition of a marketed therapy and […]
TSX News -
Suncor Energy provides fourth quarter 2018 operations update
CALGARY, Alberta, Jan. 07, 2019 (GLOBE NEWSWIRE) — Suncor today provided an operations update for the fourth quarter of 2018, […]
FCA: 2019 Corporate Calendar
2019 Corporate Calendar Fiat Chrysler Automobiles N.V. (NYSE: FCAU / MTA: FCA) announced today the following corporate calendar for year […]
Helmerich & Payne, Inc. To Participate in Goldman Sachs Global Energy Conference 2019
TULSA, Okla., Jan. 07, 2019 (GLOBE NEWSWIRE) — Helmerich & Payne, Inc. (NYSE: HP) today announced that members of management […]
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder
Demonstrated statistically significant improvement in MADRS scores compared to active comparator (p<0.001 on primary endpoint) Rapid improvement in depressive symptoms […]
